141 related articles for article (PubMed ID: 16264358)
1. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
O'Conner AR; Franc BL
Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358
[TBL] [Abstract][Full Text] [Related]
2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
5. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
Metser U; Lo G
Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
[TBL] [Abstract][Full Text] [Related]
7. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
Yang J; Zhuang H
Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
[TBL] [Abstract][Full Text] [Related]
8. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
Makis W; Lisbona R; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
[TBL] [Abstract][Full Text] [Related]
10. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
Guerra-García P; Hirsch S; Levine DS; Taj MM
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.
Marom EM; McAdams HP; Butnor KJ; Coleman RE
J Thorac Imaging; 2004 Apr; 19(2):74-8. PubMed ID: 15071322
[TBL] [Abstract][Full Text] [Related]
14. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
[TBL] [Abstract][Full Text] [Related]
15. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL
Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204
[TBL] [Abstract][Full Text] [Related]
16. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
[TBL] [Abstract][Full Text] [Related]
17. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
[No Abstract] [Full Text] [Related]
18. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
Sidell D; Venick RS; Shapiro NL
Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
[TBL] [Abstract][Full Text] [Related]
20.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
